Evidence map›Paper›PMID 37887617›Full record

ArticleBiomimetics (Basel, Switzerland)2023

Percentile-Based Adaptive Immune Plasma Algorithm and Its Application to Engineering Optimization.

Selcuk Aslan, Sercan Demirci, Tugrul Oktay, Erdal Yesilbas

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Selcuk AslanDepartment of Aeronautical Engineering, Erciyes University, Kayseri 38000, Turkey.
Sercan DemirciDepartment of Computer Engineering, Ondokuz Mayıs University, Samsun 55000, Turkey.ORCID 0000-0001-6739-7653
Tugrul OktayDepartment of Aeronautical Engineering, Erciyes University, Kayseri 38000, Turkey.ORCID 0000-0003-4860-2230
Erdal YesilbasAir Safety Department, Qatar Civil Aviation Authority, Doha 122014, Qatar.ORCID 0000-0001-9510-2023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune plasma algorithm (IP algorithm or IPA) is one of the most recent meta-heuristic techniques and models the fundamental steps of immune or convalescent plasma treatment, attracting researchers' attention once more with the COVID-19 pandemic. The IP algorithm determines the number of donors and the number of receivers when two specific control parameters are initialized and protects their values until the end of termination. However, determining which values are appropriate for the control parameters by adjusting the number of donors and receivers and guessing how they interact with each other are difficult tasks. In this study, we attempted to determine the number of plasma donors and receivers with an improved mechanism that depended on dividing the whole population into two sub-populations using a statistical measure known as the percentile and then a novel variant of the IPA called the percentile IPA (pIPA) was introduced. To investigate the performance of the pIPA, 22 numerical benchmark problems were solved by assigning different values to the control parameters of the algorithm. Moreover, two complex engineering problems, one of which required the filtering of noise from the recorded signal and the other the path planning of an unmanned aerial vehicle, were solved by the pIPA. Experimental studies showed that the percentile-based donor-receiver selection mechanism significantly contributed to the solving capabilities of the pIPA and helped it outperform well-known and state-of-art meta-heuristic algorithms.

Indexed as

adaptive selectionbig dataimmune plasma algorithmpath planningpercentileunmanned aerial vehicle

Identifiers

PMID37887617
PMCPMC10604851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.